Treeline Biosciences
PrivateLast Round
Reverse Merger
Jun 8, 2026
Est. Valuation
$2.96B
Total Funding Raised
$2B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Treeline Biosciences is a biotechnology company that develops transformative precision medicines for cancer and other serious conditions through a drug discovery platform integrating mechanistic biology, medicinal chemistry, computational science, and structural biology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treeline Biosciences Comparables
Compare Treeline Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Odyssey Therapeutics | 88% | |
| Xaira Therapeutics | 85% | |
| Valo Health | 84% | |
Treeline Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Jun 8, 2026 | ||||
| Series A | Sep 3, 2025 | ||||
| Series A | Oct 17, 2024 | ||||
| Series A | Oct 17, 2022 | ||||
| Series A | Apr 9, 2021 |
Key People
Founding team and executive leadership
Treeline Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Soleus Capital | Series A |
| Access Industries | Series A |
| Kohlberg Kravis Roberts | Series A |
| Boxer Capital | Series A |
| GV | Series A |
| Ajax Health | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 59% MoM.
- Jun 8, 2026
Raised $2.5B in an M&A round.
Treeline Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Treeline Biosciences's valuation, stock price, and market status.